Breaking News Instant updates and real-time market news.

C

Citi

$68.81

-0.39 (-0.56%)

08:38
04/25/19
04/25
08:38
04/25/19
08:38

Citi price target raised to $90 from $82 at Wells Fargo

Wells Fargo analyst Mike Mayo raised his price target for Citi to $90 from $82 given more confidence that ROTCE will improve from 11% to 13% in 2021. The analyst reiterates an Outperform rating on the shares.

  • 14

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 15

    Jul

C Citi
$68.81

-0.39 (-0.56%)

03/27/19
ODEN
03/27/19
INITIATION
ODEN
Hold
Odeon's Bove starts Citi at Hold, says 'aggressive' buybacks 'not encouraging'
Odeon Capital analyst Dick Bove initiated Citi with a Hold rating, stating that its buyback program "has been one of the most aggressive in the country," which he sees as "not encouraging" during a period of weakening in the global economy. He awaits evidence that the bank can consistently grow its book value per share, Bove tells investors.
04/15/19
BMOC
04/15/19
NO CHANGE
Target $93
BMOC
Outperform
Citi price target raised to $93 at BMO Capital after Q1 top-line beat
BMO Capital analyst James Fotheringham raised his price target on Citi to $93 and kept his Outperform rating after its revenue-driven beat in Q1 results thanks to the "higher than expected non-interest revenues". The analyst says Citi is his top pick among the "big four" U.S. banks, also citing the company's "encouraging outlook" for net interest income growth of $2B or more, expenses as "flattish", and non-interest revenues "at least flat" in 2019. Fotheringham also raises his FY19 and FY20 EPS outlook for Citi by 26c and 3c to $7.83 and $9.09 respectively.
04/17/19
JEFF
04/17/19
DOWNGRADE
Target $32
JEFF
Hold
Bank of America downgraded to Hold from Buy at Jefferies
Jefferies analyst Kenneth Usdin downgraded Bank of America (BAC) to Hold from Buy with an unchanged price target of $32. After reducing his 2020 estimates by 3% following the company's Q1 results, the analyst does not see enough upside to warrant a Buy rating. The Q1 results showed "incremental challenges in numerous revenue areas," including net interest income and fees, Usdin tells investors in a research note. He prefers putting new money into shares of Citi (C).
04/17/19
BMOC
04/17/19
NO CHANGE
Target $37
BMOC
Market Perform
Bank of America price target raised to $37 at BMO Capital after Q1 results
BMO Capital analyst James Fotheringham raised his price target on Bank of America (BAC) to $37 from $36 after its Q1 earnings beat that was driven by reduced costs and to reflect a roll out in his model by one quarter, but also lowered his FY19 EPS view by 4c to $3.05 due to lower than expected net interest income. The analyst is also keeping his Market Perform rating on the shares, stating that among the "U.S. big four banks", he prefers Citigroup (C).

TODAY'S FREE FLY STORIES

PFE

Pfizer

$43.00

-0.78 (-1.78%)

08:34
06/27/19
06/27
08:34
06/27/19
08:34
Hot Stocks
Zenith announces dosing of first patient in Phase 1b/2 trial with Pfizer »

Zenith Epigenetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 28

    Aug

  • 16

    Sep

DRRX

Durect

$0.70

0.0295 (4.40%)

08:33
06/27/19
06/27
08:33
06/27/19
08:33
Hot Stocks
Durect submits response to FDA's Complete Response Letter for Posimir »

Durect has submitted a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:33
06/27/19
06/27
08:33
06/27/19
08:33
General news
Jobless Claims data reported »

Week of 6/22 Jobless…

CPS

Cooper-Standard

$44.63

1.43 (3.31%)

08:33
06/27/19
06/27
08:33
06/27/19
08:33
Hot Stocks
Cooper-Standard names Aleksandra Miziolek as chief transformation officer »

Cooper Standard announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.90

0.06 (0.61%)

08:33
06/27/19
06/27
08:33
06/27/19
08:33
Initiation
Ford initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 24

    Jul

  • 23

    Oct

EVOK

Evoke Pharma

$0.53

-0.0325 (-5.74%)

08:32
06/27/19
06/27
08:32
06/27/19
08:32
Hot Stocks
Evoke Pharma request Type A FDA meeting for resubmission of Gimoti NDA »

Evoke Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$2.50

-0.11 (-4.21%)

08:32
06/27/19
06/27
08:32
06/27/19
08:32
Hot Stocks
OncoSec enters collaboration with Dana-Farber Cancer Institute »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:31
06/27/19
06/27
08:31
06/27/19
08:31
Recommendations
Esperion analyst commentary  »

Esperion funding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQBG

Sequential Brands

$0.50

-0.0049 (-0.98%)

08:30
06/27/19
06/27
08:30
06/27/19
08:30
Hot Stocks
NBA player Montrezl Harrell signs multi-year sneaker, apparel deal with AND1 »

AND1 and its newest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEX

Apex Global Brands

$0.60

0.0999 (19.98%)

, ARVN

Arvinas

$23.38

0.93 (4.14%)

08:30
06/27/19
06/27
08:30
06/27/19
08:30
Options
Four new option listings and one option delisting on June 27th »

New option listings for…

APEX

Apex Global Brands

$0.60

0.0999 (19.98%)

ARVN

Arvinas

$23.38

0.93 (4.14%)

LOVE

Lovesac

$28.99

-0.83 (-2.78%)

PRVB

Provention Bio

$11.41

-0.805 (-6.59%)

CHKE

Cherokee

$0.60

0.0999 (19.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTV

Aptiv

$78.87

0.72 (0.92%)

08:29
06/27/19
06/27
08:29
06/27/19
08:29
Initiation
Aptiv initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$0.94

-0.26 (-21.67%)

08:28
06/27/19
06/27
08:28
06/27/19
08:28
Upgrade
Gemphire Therapeutics rating change  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
Esperion reaches $200M revenue-based funding agreement with Oberland Capital »

Esperion and an investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNA

CareDx

$34.68

-0.99 (-2.78%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
CareDx 'applauds' progress in Medicare immunosuppressive medication legislation »

CareDx said it,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAN

Dana

$18.38

0.74 (4.20%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Initiation
Dana initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.